Business Description
Virpax Pharmaceuticals Inc
NAICS : 541714
SIC : 2833
ISIN : US9282511073
Share Class Description:
VRPX: Ordinary SharesDescription
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -6.75 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -15.9 | |||||
| 3-Year EPS without NRI Growth Rate | -13.4 | |||||
| 3-Year FCF Growth Rate | -39.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 65.39 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.91 | |||||
| 9-Day RSI | 38.54 | |||||
| 14-Day RSI | 36.69 | |||||
| 6-1 Month Momentum % | 14.06 | |||||
| 12-1 Month Momentum % | -84.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | |||||
| Quick Ratio | 0.13 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -37.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -2779.92 | |||||
| ROA % | -230.7 | |||||
| ROIC % | -399.55 | |||||
| ROCE % | -3145.65 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.18 | |||||
| EV-to-EBITDA | -0.18 | |||||
| EV-to-FCF | -0.16 | |||||
| Earnings Yield (Greenblatt) % | -555.56 | |||||
| FCF Yield % | -631.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VRPX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Virpax Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -8.83 | ||
| Beta | 0.01 | ||
| Volatility % | 182.04 | ||
| 14-Day RSI | 36.69 | ||
| 14-Day ATR ($) | 0.065025 | ||
| 20-Day SMA ($) | 0.369445 | ||
| 12-1 Month Momentum % | -84.03 | ||
| 52-Week Range ($) | 0.286 - 5.48 | ||
| Shares Outstanding (Mil) | 8.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Virpax Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Virpax Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Virpax Pharmaceuticals Inc Frequently Asked Questions
What is Virpax Pharmaceuticals Inc(VRPX)'s stock price today?
The current price of VRPX is $0.33. The 52 week high of VRPX is $5.48 and 52 week low is $0.29.
When is next earnings date of Virpax Pharmaceuticals Inc(VRPX)?
The next earnings date of Virpax Pharmaceuticals Inc(VRPX) is 2025-03-26 Est..
Does Virpax Pharmaceuticals Inc(VRPX) pay dividends? If so, how much?
Virpax Pharmaceuticals Inc(VRPX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers